NCT06384508

Brief Summary

Suffering from PTSD in childhood can have detrimental formative consequences. Researchers have been eager to develop effective interventions and to enhance treatment motivation since the introduction of the diagnosis of PTSD in the DSM. With evolving understanding of the disorder, its definition and criteria have changed over the course of time. The most recent change involves the addition of the criterium D of negative affects or emotions in relation to PTSD, the feeling of shame amongst others. Individuals experiencing interpersonal trauma, such as sexual abuse, are at high-risk developing trauma-related shame, which in turn can impact the course and effectiveness of PTSD treatment. Shame-inducing situations are typically being avoided, and the feelings are not disclosed to peers and other people. Hence, acknowledging and sharing feelings of shame as well as practicing self-compassion have been proposed to reduce the impact of that negative self-conscious emotion. These aspects get partially tackled in evidence-based trauma therapies, however, there appears to be a need for a more specific trauma-related shame intervention in addition to existing treatments. Recent research has focused on developing such interventions for adults and has reported positive effects. To our knowledge, there is no intervention specifically tackling trauma-related shame in adolescents. Virtual Reality (VR) is a promising tool for such an intervention. Findings suggest that including VR in a treatment results in high treatment satisfaction and that it is highly motivating for its users, which is a crucial component for treatment success. The goal of this study is to test the effectiveness of a short-term VR shame intervention (SHINE-VR) for adolescents suffering from PTSD after having experienced sexual abuse. The primary objectives of this study to assess the effect of SHINE-VR on trauma-related shame, self-compassion, and PTSD symptom reduction, to investigate whether treatment motivation, an increase in self-compassion, and a decrease in trauma-related shame are associated with PTSD symptom reduction.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
6

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Feb 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

5 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 1, 2024

Completed
2 months until next milestone

First Posted

Study publicly available on registry

April 25, 2024

Completed
9 months until next milestone

Study Start

First participant enrolled

February 3, 2025

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 19, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 19, 2025

Completed
Last Updated

December 15, 2025

Status Verified

August 1, 2025

Enrollment Period

4 months

First QC Date

March 1, 2024

Last Update Submit

December 5, 2025

Conditions

Keywords

shamesexual abusevirtual realityself-compassion

Outcome Measures

Primary Outcomes (2)

  • Trauma-related shame

    Shame experienced in relation to sexual abuse will be measured with a self-developed questionnaire. The first 4 items are based on the Dutch translation of the Shame and Guilt After Trauma Scale. Each item is rated on a 5-point Likert scale. Higher scores mean worse outcome. 2 items are reversed. Higher scores mean worse outcome.

    Daily throughout the 6 weeks, resulting in 42 assessments

  • Self-compassion

    Self-compassion will be measured with the Dutch translation of the Self-Compassion Scale-Youth version. Each of the 6 items is rated on a 1-5 Likert scale, 3 of them are reversed. The outcome measure is the sum score of all items divided by the number of items. Higher scores mean better outcome.

    Daily throughout the 6 weeks, resulting in 42 assessments

Secondary Outcomes (1)

  • PTSD symptoms

    Daily on weekdays throughout the 6 weeks, resulting in 30 assessments

Study Arms (2)

SHINE-VR Baseline 1 week

ACTIVE COMPARATOR

Participants will receive SHINE-VR additionally to regular trauma treatment. The baseline phase starts after trauma processing, e.g. after module 6 of TF-CBT or processing of the traumatic event with EMDR. This group has a one week baseline, 3 weeks intervention, and 2 week follow-up phase.

Behavioral: SHINE-VR

SHINE-VR Baseline 2 weeks

ACTIVE COMPARATOR

Participants will receive SHINE-VR additionally to regular trauma treatment. The baseline phase starts after trauma processing, e.g. after module 6 of TF-CBT or processing of the traumatic event with EMDR. This group has a two week baseline, 3 weeks intervention, and a 1 week follow-up phase.

Behavioral: SHINE-VR

Interventions

SHINE-VRBEHAVIORAL

The SHINE-VR takes place after trauma processing, e.g. after module 6 of TF-CBT or processing of the traumatic event with EMDR, and is followed by the rest of the regular treatment. SHINE-VR consists of the following 3 VR sessions à 45min: * Introduction: getting acquainted with VR, playing a VR game developed for the feasibility study (Krupljanin et al., in preparation), receiving psychoeducation about seeking help. * Shame: virtual group therapy setting, psychoeducation about shame, virtual peers sharing thoughts of shame and their learnings/positive affirmations. * Self-compassion: practicing self-compassion using an immersive perspective-changing task in VR.

SHINE-VR Baseline 1 weekSHINE-VR Baseline 2 weeks

Eligibility Criteria

Age12 Years - 17 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Interpersonal trauma (sexual abuse); in case of multiple traumas the main trauma should be sexual abuse
  • Indication for PTSD treatment
  • Getting trauma treatment as usual
  • Adequate command of the Dutch language

You may not qualify if:

  • Known mental disability
  • Epilepsy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (5)

GGZ Delfland

The Hague, Haaglanden, Netherlands

Location

iMindU Practice for Child, Adolescent and Adult Psychiatry

Leiden, South Holland, 2311 EX, Netherlands

Location

LEVVEL

Amsterdam, Netherlands

Location

Kenter Jeugdhulp

Haarlem, Netherlands

Location

LUMC Curium

Oegstgeest, 2342AK, Netherlands

Location

Related Publications (4)

  • Aakvaag HF, Thoresen S, Wentzel-Larsen T, Dyb G, Roysamb E, Olff M. Broken and guilty since it happened: A population study of trauma-related shame and guilt after violence and sexual abuse. J Affect Disord. 2016 Nov 1;204:16-23. doi: 10.1016/j.jad.2016.06.004. Epub 2016 Jun 11.

  • Neff KD, Bluth K, Toth-Kiraly I, Davidson O, Knox MC, Williamson Z, Costigan A. Development and Validation of the Self-Compassion Scale for Youth. J Pers Assess. 2021 Jan-Feb;103(1):92-105. doi: 10.1080/00223891.2020.1729774. Epub 2020 Mar 3.

  • Sachser C, Berliner L, Risch E, Rosner R, Birkeland MS, Eilers R, Hafstad GS, Pfeiffer E, Plener PL, Jensen TK. The child and Adolescent Trauma Screen 2 (CATS-2) - validation of an instrument to measure DSM-5 and ICD-11 PTSD and complex PTSD in children and adolescents. Eur J Psychotraumatol. 2022 Aug 1;13(2):2105580. doi: 10.1080/20008066.2022.2105580. eCollection 2022.

  • Drieschner KH, Boomsma A. Validation of the Treatment Motivation Scales for Forensic outpatient treatment (TMS-F). Assessment. 2008 Jun;15(2):242-55. doi: 10.1177/1073191107311651. Epub 2008 Feb 1.

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Masking Details
The participants are unaware of different baseline lengths
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Single Case Experimental Design (ABC) with two different baseline lengths
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

March 1, 2024

First Posted

April 25, 2024

Study Start

February 3, 2025

Primary Completion

May 19, 2025

Study Completion

May 19, 2025

Last Updated

December 15, 2025

Record last verified: 2025-08

Data Sharing

IPD Sharing
Will share

Identifiable information of the participants will be encrypted for the further processing and analyzing of the corresponding data. Once the project is completed and the paper(s) has been published, the encryption key and the personal data will be deleted. Following paragraph from the template of the Institute of Education and Child Studies will be used: I consent to my and my child's participation in the study (Title Research) I also give permission to store and use the pseudonymised research data about me and my child that is collected in this research and to share it with other researchers if necessary.

Shared Documents
STUDY PROTOCOL, SAP
Time Frame
We will store the data according to the University regulations on data management of projects assessed by the Medical Ethical committee, allowing the data to be FAIR for at least 15 years after publication.
Access Criteria
A CC-BY license will be used. Since sensitive data will be collected, it will only be shared with researchers upon request. Requests for information will be reviewed by the first and last author.
More information

Locations